Reprogrammable RNA nanoparticles activate only in cancer cells to deliver targeted gene-silencing therapy while avoiding off-target effects, immune activation, and unnecessary drug exposure. (Nanowerk ...

Scientists are uncovering what makes some carcinomas so resistant: their ability to change identity. Two new studies reveal crucial proteins and structures that could become targets for future ...